Arabinda Das

Prof. Arabinda Das

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2004 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
ADArabinda Das
Arabinda Das
NBNaren L. Banik
Naren L. Banik
SPSunil J Patel
Sunil J Patel
SRSwapan K Ray
Swapan K Ray
Glioblastoma is the deadliest and most prevalent brain tumor. Dexamethasone (DXM) is a commonly used steroid for treating glioblastoma patients for alleviation of vasogenic edema and pain prior to treatment with chemotherapeutic drugs. Temozolomide (TMZ), an alkylating agent, has recently been introduced in clinical trials for treating glioblastoma. Here, we evaluated the modulatory effect of DXM on TMZ induced apoptosis in human glioblastoma U87MG cells. Freshly grown cells were treated with different doses of DXM or TMZ for 6 h followed by incubation in a drug-free medium for 48 h. Wright staining and ApopTag assay showed no apoptosis in cells treated with 40 μM DXM but considerable amounts of apoptosis in cells treated with 100 μM TMZ. Apoptosis in TMZ treated cells was associated with an increase in intracellular free [Ca2+], as determined by fura-2 assay. Western blot analyses showed alternations in the levels of Bax (pro-apoptotic) and Bcl-2 (anti-apoptotic) proteins resulting in increased Bax:Bcl-2 ratio in TMZ treated cells. Western blot analyses also detected overexpression of calpain and caspase-3, which cleaved 270 kD α-spectrin at specific sites for generation of 145 and 120 kD spectrin break down products (SBDPs), respectively. However, 1-h pretreatment of cells with 40 μM DXM dramatically decreased TMZ induced apoptosis, decreasing Bax:Bcl-2 ratio and SBDPs. Our results revealed an antagonistic effect of DXM on TMZ induced apoptosis in human glioblastoma U87MG cells, implying that treatment of glioblastoma patients with DXM prior to chemotherapy with TMZ might result in an undesirable clinical outcome.

11 June 2013 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
GWGerald C. Wallace
Gerald C. Wallace
CHCatherine P. Haar
Catherine P. Haar
WVW. Alex Vandergrift
W. Alex Vandergrift
PGPierre Giglio
Pierre Giglio
YDYaenette N. Dixon-Mah
Yaenette N. Dixon-Mah
ADArabinda Das
Arabinda Das

1 February 2015
Verified
Journal Article
Closed access
PLPhilip Lee
Philip Lee
BMBen Murphy
Ben Murphy
RMRickey Miller
Rickey Miller
VMVivek Menon
Vivek Menon
NBNaren L Banik
Naren L Banik
ADArabinda Das
Arabinda Das

12 April 2015 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
ADArabinda Das
Arabinda Das
RMRickey Miller
Rickey Miller
PLPhilip Lee
Philip Lee
CHChrysanthe Alyssa Holden
Chrysanthe Alyssa Holden
SLScott M. Lindhorst
Scott M. Lindhorst
SPSunil J. Patel
Sunil J. Patel

18 December 2015 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
ADArabinda Das
Arabinda Das
DMDaniel G. McDonald
Daniel G. McDonald
YDYaenette N. Dixon-Mah
Yaenette N. Dixon-Mah
DJDustin J. Jacqmin
Dustin J. Jacqmin
VSVikram N. Samant
Vikram N. Samant
SPSunil J. Patel
Sunil J. Patel